Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics.
Tasneem S, Alam MM, Amir M, Akhter M, Parvez S, Verma G, Nainwal LM, Equbal A, Anwer T, Shaquiquzzaman M.
Tasneem S, et al. Among authors: anwer t.
Mini Rev Med Chem. 2022;22(12):1648-1706. doi: 10.2174/1389557519666211221144013.
Mini Rev Med Chem. 2022.
PMID: 34939540
Review.